Patients with elevated levels of CSF glucose and plasma sICOSL, increased percentages of peripheral blood CD4+ICOS+ and CD19+PD-L1+, and symptoms of cognitive impairment were more likely to be diagnosed with AE. The gene discussed is CD4; the disease is Cognitive impairment.